Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Exo to Acquire Canadian Artificial Intelligence Technology Developer Medo AI.

Document Cited in Related
Vincent

MANews-(C)2009-2022

US-based health information and medical devices company Exo (pronounced "echo") is acquiring Canadian artificial intelligence technology developer Medo, the company said.

Exo said that, by integrating Medo's proprietary Sweep AI technology into its ultrasound platform, the company will make ultrasound imaging more accessible to a wider range of caregivers.

Medo's unique ultrasound AI technology radically lowers the expertise required to diagnose common and critical conditions through automated image acquisition and interpretation, allowing non-experts to conduct high-quality exams quickly and accurately.

Medo's two FDA-cleared AI algorithms, with more in development, combined with access to an extensive library of millions of ultrasound images and longitudinal health data bring a unique opportunity to speed point-of-care ultrasound adoption across the healthcare...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT